Literature DB >> 35066114

Short chain fatty acids: Microbial metabolites for gut-brain axis signalling.

Kenneth J O'Riordan1, Michael K Collins2, Gerard M Moloney2, Emily G Knox3, María R Aburto1, Christine Fülling1, Shane J Morley1, Gerard Clarke4, Harriët Schellekens2, John F Cryan5.   

Abstract

The role of the intestinal microbiota as a regulator of gut-brain axis signalling has risen to prominence in recent years. Understanding the relationship between the gut microbiota, the metabolites it produces, and the brain will be critical for the subsequent development of new therapeutic approaches, including the identification of novel psychobiotics. A key focus in this regard have been the short-chain fatty acids (SCFAs) produced by bacterial fermentation of dietary fibre, which include butyrate, acetate, and propionate. Ongoing research is focused on the entry of SCFAs into systemic circulation from the gut lumen, their migration to cerebral circulation and across the blood brain barrier, and their potential to exert acute and chronic effects on brain structure and function. This review aims to discuss our current mechanistic understanding of the direct and indirect influence that SCFAs have on brain function, behaviour and physiology, which will inform future microbiota-targeted interventions for brain disorders.
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Microbiome; Microbiota; Microbiota-gut-brain axis; Short-chain fatty acids

Mesh:

Substances:

Year:  2022        PMID: 35066114     DOI: 10.1016/j.mce.2022.111572

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  7 in total

Review 1.  Diet and the microbiota - gut - brain-axis: a primer for clinical nutrition.

Authors:  Gabriela Ribeiro; Aimone Ferri; Gerard Clarke; John F Cryan
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2022-09-14       Impact factor: 3.620

Review 2.  Blood-Based Biomarkers for Alzheimer's Disease Diagnosis and Progression: An Overview.

Authors:  Angelica Varesi; Adelaide Carrara; Vitor Gomes Pires; Valentina Floris; Elisa Pierella; Gabriele Savioli; Sakshi Prasad; Ciro Esposito; Giovanni Ricevuti; Salvatore Chirumbolo; Alessia Pascale
Journal:  Cells       Date:  2022-04-17       Impact factor: 7.666

Review 3.  Making Sense of Quorum Sensing at the Intestinal Mucosal Interface.

Authors:  Friederike Uhlig; Niall P Hyland
Journal:  Cells       Date:  2022-05-24       Impact factor: 7.666

Review 4.  Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and Treatment.

Authors:  Eduardo Duarte-Silva; Sven G Meuth; Christina Alves Peixoto
Journal:  Front Neurosci       Date:  2022-04-28       Impact factor: 4.677

Review 5.  The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management.

Authors:  Ali Nabavi-Rad; Amir Sadeghi; Hamid Asadzadeh Aghdaei; Abbas Yadegar; Sinéad Marian Smith; Mohammad Reza Zali
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 6.  The Microbiota-Gut-Brain Axis in Psychiatric Disorders.

Authors:  Aleksandra Góralczyk-Bińkowska; Dagmara Szmajda-Krygier; Elżbieta Kozłowska
Journal:  Int J Mol Sci       Date:  2022-09-24       Impact factor: 6.208

Review 7.  Influence of the Gut Microbiota on the Development of Neurodegenerative Diseases.

Authors:  Mahendra P Singh; Riya Chakrabarty; Shabnam Shabir; Sumaira Yousuf; Ahmad A Obaid; Mahmoud Moustafa; Mohammed Al-Shehri; Ahmed Al-Emam; Abdulhakeem S Alamri; Walaa F Alsanie; Majid Alhomrani; Anastasiia D Shkodina; Sandeep K Singh
Journal:  Mediators Inflamm       Date:  2022-09-30       Impact factor: 4.529

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.